Hookipa Pharma is a biopharmaceutical company focused on developing innovative therapies for cancer and viral infections

The company utilizes its proprietary virus-enhanced immunotherapy platform to create treatments that harness and boost the immune system's natural ability to fight disease. By advancing its pipeline of targeted therapeutic candidates, Hookipa aims to improve patient outcomes and provide new options for individuals afflicted with challenging health conditions. Their approach emphasizes both the development of personalized medicine and the exploration of novel therapeutic mechanisms to address unmet medical needs.